Improve upper limb motor learning

Trial ID
NCT05960331
Official Title
Influence of Autonomy on Motor Learning in People With Parkinson's Disease
Goal
Improve upper limb motor learning
Phase
NA
Status
RECRUITING
Sponsor
National Taiwan University Hospital
Study Type
INTERVENTIONAL
Enrollment
72 participants
Conditions
Parkinson Disease
Interventions
Autonomy supported learning, Practice with predetermined feedback

Plain-Language Summary

The goal is to see whether giving people with Parkinson's more control over how they practice movements helps them learn and retain motor skills better, which could make rehabilitation and everyday tasks easier. Participants either use autonomy-supported learning, where they choose aspects of practice and when they receive feedback to boost motivation and engagement and promote stronger motor memory, or they follow a fixed practice plan with predetermined feedback for comparison. The trial is looking for adults over 20 who can follow instructions and have reasonable cognition (MoCA ≥ 24), with no recent upper-limb surgery; people with Parkinson's dementia, severe upper-limb tremor, implanted DBS or pacemakers, seizure risk, unstable medical conditions, or pregnancy are excluded.

Locations

  • National Taiwan University Hospital, Taipei, Taiwan

Frequently Asked Questions

What is this trial testing?
This trial is studying Autonomy supported learning. The goal is to see whether giving people with Parkinson's more control over how they practice movements helps them learn and retain motor skills better, which could make rehabilitation and everyday tasks easier. Participants either use autonomy-supported learning, where they choose aspects of practice and when they receive feedback to boost motivation and engagement and promote stronger motor memory, or they follow a fixed practice plan with predetermined feedback for comparison. The trial is looking for adults over 20 who can follow instructions and have reasonable cognition (MoCA ≥ 24), with no recent upper-limb surgery; people with Parkinson's dementia, severe upper-limb tremor, implanted DBS or pacemakers, seizure risk, unstable medical conditions, or pregnancy are excluded.
Who can participate?
Participants must be at least 20 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 1 year and 11 months.

View on ClinicalTrials.gov